1. Home
  2. BZUN vs RNA Comparison

BZUN vs RNA Comparison

Compare BZUN & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

SELL

Current Price

$3.82

Market Cap

164.5M

ML Signal

SELL

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

SELL

Current Price

$7.79

Market Cap

141.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BZUN
RNA
Founded
2007
2025
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
141.3M
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
BZUN
RNA
Price
$3.82
$7.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$4.58
★ $25.00
AVG Volume (30 Days)
★ 300.9K
297.6K
Earning Date
11-24-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.08
$84.55
Revenue Next Year
$7.45
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$7.54
52 Week High
$3.82
$73.06

Technical Indicators

Market Signals
Indicator
BZUN
RNA
Relative Strength Index (RSI) 72.38 30.90
Support Level $2.74 $7.63
Resistance Level N/A $8.50
Average True Range (ATR) 0.20 0.33
MACD 0.05 0.11
Stochastic Oscillator 92.79 22.92

Price Performance

Historical Comparison
BZUN
RNA

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: